enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The Zepbound Shortage Is Over — Here's What to Expect ... - AOL

   www.aol.com/zepbound-shortage-over-heres-expect...

   Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...

3. Eli Lilly to sell Zepbound directly to consumers without ...

   www.aol.com/eli-lilly-sell-zepbound-directly...

   Eli Lilly, the maker of Zepbound, announced Tuesday it will begin selling the weight loss drug directly to consumers through the company's direct pharmacy, LillyDirect.

4. Ro partners with Eli Lilly to expand access to Zepbound vials

   www.aol.com/finance/ro-partners-eli-lilly-expand...

   Eli Lilly has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug Zepbound.Ro is joining other telehealth platforms and Amazon Pharmacy in ...

5. What to know about new weight-loss drug Zepbound and ... - AOL

   www.aol.com/news/know-weight-loss-drug-zepbound...

   Prescriptions for Zepbound, which was approved by the U.S. Food and Drug Administration on Nov. 8, can be filled at retail and mail-order pharmacies as of Dec. 5, drug maker Eli Lilly announced.

6. New weight-loss drug Zepbound now available in US pharmacies

   www.aol.com/news/weight-loss-drug-zepbound-now...

   There is a cost barrier for people who want to get on Zepbound. It costs $1,059 per month without insurance. However, Eli Lilly said its savings card program is available at U.S. pharmacies.

7. Telehealth Firm Ro Partners With Eli Lilly to Boost Access to ...

   www.aol.com/finance/telehealth-firm-ro-partners...

   On average, Zepbound led to a superior weight loss of 20.2% compared to 13.7% with Wegovy. Price Action: At last check Thursday, LLY stock was up 0.31% at $798.50. Read Next:

8. Eli Lilly obesity drug now available in US pharmacies - AOL

   www.aol.com/news/eli-lillys-obesity-drug-now...

   Wall Street analysts expect sales of Zepbound to reach about $2 billion in 2024, and for sales of Novo Nordisk's rival obesity drug Wegovy to hit around $7.5 billion.

9. Lilly launches vials of weight-loss drug Zepbound for as low ...

   www.aol.com/news/lilly-launches-single-dose...

   Eli Lilly said on Tuesday it has begun selling vials of the lowest starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month's supply through its direct-to ...